Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03633851
Other study ID # ASPH2016-01
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 3, 2017
Est. completion date August 2019

Study information

Verified date August 2018
Source Ashford and St. Peter's Hospitals NHS Trust
Contact Isaac John, PhD
Phone 0044 193 272 2901
Email Isaac.John@nhs.net
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to compare the astigmatism reducing effect of a toric intraocular lens (IOL) (model MX60T - Bausch & Lomb) with that of limbal relaxing incisional surgery combined with a non toric IOL (model MX60 - Bausch & Lomb) in patients with corneal astigmatism between 1.0 and 1.5 diopters and also the effect of cylinder reduction on patient's quality of vision.


Description:

This is a randomised controlled trial with intra-patient comparison (bilateral study) in which study patients will be randomized by a medical statistician to the implantation of the toric intraocular lens (IOL) (model MX60T, Bausch & Lomb) in one eye and the non-toric IOL model MX60 plus LRI in the fellow eye.

During pre-operative examination, the patient will undergo:

- An ophthalmic examination including slit lamp biomicroscopy and retinal examination;

- Uncorrected and best-corrected visual acuity (UCVA and BCVA): monocular and binocular;

- Optical biometry with IOLMaster (Carl Zeiss Meditec);

- Orbscan corneal topography (Bausch and Lomb Orbscan IIz Corneal Analysis System);

- Quality of Vision (QoV) questionnaire score). It is a validated, Rasch-adjusted questionnaire in which patients are asked to rate 10 dysphotopsia items illustrated by standard photographs, scoring each item (0, 1, 2, 3) in relation to how frequent, severe, and bothersome their symptoms are (30 items in total).

- Catquest 9-SF cataract visual disability questionnaire. It is a Rasch-adjusted cataract visual disability questionnaire that asks patients to rate difficulty with a range of vision-related daily activities.

The appropriate cylinder power of the MX60T toric-IOL as well of its axis of implantation will be calculated with the calculator provided by the manufacturer Bausch + Lomb (https://trulign.toriccalculator.com).

Subsequently, the patient will undergo cataract surgery with IOL implantation under local anaesthesia.

The temporal self-sealing incision, injection of viscoelastic substance, capsulorhexis, phacoemulsification, irrigation/aspiration of cortical material and injection of viscoelastic substance into the capsular bag will be performed as standard procedure.

According to randomisation, each patient will receive the implantation of the MX60T toric-IOL in one eye and the MX60 non-toric IOL combined with limbal relaxing incisions (LRI) in the fellow eye.

The eye that will receive the toric-IOL will have the horizontal meridian marked preoperatively at the limbus in the sitting position with a blue marking pen and insulin syringe.

The IOL will be implanted via injector into the capsular bag using the manufacturers' recommended IOL loading and injection technique.

The toric-IOL will be rotated in the capsular bag so that the axis markers on the IOL will be aligned to the limbal markings (planned axis). Then, the viscoelastic substance will be aspirated thoroughly from the eye. Final refinement of axis position of the IOL will be undertaken after removal of viscoelastic material from the capsular bag to ensure that irrigation/aspiration of viscoelastic does not move the lens off axis.

The fellow eye will receive a temporal or an on-axis incision with limbal relaxing incision with a 600µm single-use steel blade combined with the MX60 non-toric IOL (http://www.lricalculator.com).

The interval between the first and second eye surgery will be recorded. The location and length of the LRIs will be made after calculation according to the Donnenfeld nomogram (www.lricalculator.com).

After one hour postoperatively, a photo of the toric-IOL in retroillumination will be taken to evaluate if IOL is on axis.

At six months and twelve months after the surgery performed in the second eye, patients will undergo assessement of:

- autorefraction;

- unaided and best-spectacle corrected visual acuity (monocular and binocular),

- optical biometry;

- corneal topography;

- photo of the toric-IOL in retroillumination (to evaluate if IOL is on axis);

- Catquest 9-SF cataract visual disability questionnaire;

- Quality of Vision (QoV) questionnaire score;

- Overall satisfaction with vision rating questionnaire (only at 6 months and 12 months). It will be obtained by asking patients to rate whether they were very satisfied, satisfied, neither satisfied nor unsatisfied, unsatisfied, or very unsatisfied.

- Dysphotopsia questionnaire. They are 4 questions regarding dysphotopsia symptoms: "Since your surgery, have you noticed any" halo, glare or dazzle, unwanted images, or shadows? Patients were asked to respond by indicating whether they had not experienced these symptoms at all ("none") or found them "barely noticeable," "annoying," or "debilitating."

Statistical analysis will be performed using SPSS for Macintosh software (version 20.0, International Business Machines Corp.). Normality distribution will be tested with the Shapiro-Wilk test; data will be considered normal if the p value is less than 0.05. The central tendency and statistical dispersion of each parameter will be recorded as the mean and standard deviation (SD) for normal data and as the median and interquartile difference for nonparametric data. The coordinates of keratometric cylinders and the centroids will be calculated according to the Alpins method. Double-angle polar plots will be used to display the astigmatism analysis (Excel 2011 for Macintosh, Microsoft Corp.).

The Student t test for paired samples and the Wilcoxon signed-rank test will be used for normal and nonparametric data, respectively, to compare the 2 related samples.

A statistically significant difference will be defined as a p value less than 0.05.

Any adverse event will be recorded.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date August 2019
Est. primary completion date August 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria:

- Bilateral cataract.

- Age 21 and older.

- Written informed consent to sequential bilateral surgery and participation in the study.

- Preoperative pupil size greater than or equal to 5.0 mm in the study eye.

- IOL power as predicted by biometry ranging from 6.0 D to 30.0 D in both eyes.

- Regular corneal astigmatism according to Orbscan topography.

- Postoperative corneal astigmatism between 0.90 D and 1.40 D in both eyes, as predicted by the Bausch + Lomb Toric Calculator (https://envista.toriccalculator.com).

Exclusion Criteria:

- Ocular comorbidity (corneal scars, amblyopia, retina, or optic nerve disease) that may reduce postoperative CDVA

- Reduced zonular or capsular stability (e.g. Marfan syndrome, previous eye trauma)

- Irregular corneal astigmatism on Orbscan topography

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Toric intraocular MX60T lens
one eye will receive toric MX60T lens
Other:
Standard MX60 plus corneal incisions
the other eye will receive standard MX60 lens with corneal incisions

Locations

Country Name City State
United Kingdom Dr Isaac John Chertsey Surrey

Sponsors (2)

Lead Sponsor Collaborator
Ashford and St. Peter's Hospitals NHS Trust Bausch & Lomb Incorporated

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Astigmatism reduction effect of toric intraocular lens (IOL) versus non-toric IOL with limbal relaxing incisions. Astigmatism reduction will be evaluated with optical biometry, corneal topography 6 months and 12 months
Primary Astigmatism reduction effect of toric intraocular lens (IOL) versus non-toric IOL Astigmatism reduction will be evaluated with manifest refraction, autorefraction 6 months and 12 months
Secondary Unaided visual acuity after toric intraocular lens (IOL) versus non-toric IOL with limbal relaxing incisions. Measurement of uncorrected visual acuity, monocular and binocular, will be done using a back-lit EDTRS chart placed at 4m. Although these assessments appear to have different units of measurements, but all the measurements will be in the same units of measure. 6 months and 12 months
Secondary Best-spectacle corrected visual acuity after toric intraocular lens (IOL) versus non-toric IOL with limbal relaxing incisions. Measurement of best-spectacle corrected visual acuity, monocular and binocular, will be done using a back-lit EDTRS chart placed at 4m. 6 months and 12 months
Secondary Quality of Vision Quality of Vision will be evaluated with the QoV (Quality of Vision) questionnaire score. It is a validated, Rasch-adjusted questionnaire in which patients are asked to rate 10 dysphotopsia items illustrated by standard photographs, scoring each item (0, 1, 2, 3) in relation to how frequent, severe, and bothersome their symptoms are (30 items in total). 6 months and 12 months
Secondary Visual disability Visual disability will be evaluated with the Catquest 9-SF cataract visual disability questionnaire. It is a Rasch-adjusted cataract visual disability questionnaire that asks patients to rate difficulty with a range of vision-related daily activities. 6 months and 12 months
Secondary Overall satisfaction Overall satisfaction will be evaluated with vision rating questionnaire. It will be obtained by asking patients to rate whether they were very satisfied, satisfied, neither satisfied nor unsatisfied, unsatisfied, or very unsatisfied. 6 months and 12 months
Secondary Dysphotopsia Dysphotopsia will be evaluated with the Dysphotopsia questionnaire. They are 4 questions regarding dysphotopsia symptoms: "Since your surgery, have you noticed any" halo, glare or dazzle, unwanted images, or shadows? Patients were asked to respond by indicating whether they had not experienced these symptoms at all ("none") or found them "barely noticeable," "annoying," or "debilitating." 6 months and 12 months
See also
  Status Clinical Trial Phase
Completed NCT03050697 - Evaluation of the Safety and Performance of the HARMONI® Toric Lens N/A
Completed NCT01763151 - Comparison of Toric IOL Implantation and Opposite Clear Corneal Incision During Cataract Surgery to Correct Corneal Astigmatism Phase 4
Completed NCT05129566 - Evaluation of Axial Stability of Two Models of Intraocular Lenses in Patients With an Eye Length More Than 26 mm N/A
Recruiting NCT01122992 - Prospective Evaluation of Limbal Relaxing Incision (LRI) in Conjunction With Phacoemulsification Surgery for Astigmatic Correction in Chinese Eyes N/A
Completed NCT04528069 - Clinical Investigation of the Visual Outcomes and Safety of a Trifocal Toric IOL in an Asian Population N/A
Not yet recruiting NCT05593263 - Limbal Relaxing Incisions Versus Paired 4 mm Clear Corneal Incisions on Steep Meridian During Phacoemulsification N/A
Recruiting NCT06256770 - Evaluation of the Safety and Efficacy of Rigid Breathable Scleral Contact Lenses for the Correction of Ametropia
Completed NCT01348854 - Safety and Effectiveness of Arcuate Incisions Performed With the iFS Femtosecond Laser System Phase 2
Not yet recruiting NCT05263518 - Influence of Different Toric Intraocular Lenses on IOL-capsular Complex N/A
Completed NCT03162471 - How Astigmatism Influences Corneal Biomechanics and Intraocular Pressure N/A
Completed NCT05075746 - Retrospective Chart Review of enVista Toric 0.9D Intraocular Lenses
Completed NCT03264534 - Manually Performed Limbal Relaxing Incisions vs Femtosecond Laser-guided Astigmatic Keratotomy N/A
Completed NCT02155959 - Performance of a Single-piece Toric Acrylic Intraocular Lens N/A
Completed NCT04652037 - Visual Results of the Acrysof IQ Vivity Toric Extended Vision Intraocular Lens N/A
Recruiting NCT04251143 - Dresden Corneal Disease and Treatment Study
Completed NCT03097302 - Tomographic Analysis of Anterior, Posterior, Total Corneal Refractive Power Changes After Laser-assisted Keratotomy N/A
Completed NCT03054649 - ClarVista HARMONI Toric Trial With Intraoperative Exchange N/A
Completed NCT04890249 - Clinical Investigation of Two Tecnis Investigational Lenses N/A
Completed NCT04327518 - Evaluation of the Rotational Stability of the Tecnis Toric II IOL N/A
Completed NCT04475900 - Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics